P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG-TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML-001 TRIAL OF ORAL AZACITIDINE

Authors: Wei, A. H., Döhner, H., Sayar, H., Ravandi, F., Montesinos, P., Dombret, H., Selleslag, D., Porkka, K., Jang, J.-H., Skikne, B., Beach, C., Prebet, T., Zhang, G., Risueño, A., Ugidos Guerrero, M., See, W. L., Menezes, D., Roboz, G. J.

Source: HemaSphere. 6:397-398

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165725826.0x000001&indx=1&recIds=ETOCvdc_100165725826.0x000001